Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trialZhiCheng Lai, Ming Shi, YaoJun Zhang et al.|European Journal of Cancer|2022Cited by 154
One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinomaZhiCheng Lai, Ming Shi, YeXing Huang et al.|BMC Medicine|2022Cited by 35
Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular CarcinomaRun-Bin Liang, Ming Shi, Yang Zhao et al.|Frontiers in Oncology|2021Cited by 20
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective TrialsYeXing Huang, Anna Kan, Lihong Zhang et al.|Technology in Cancer Research & Treatment|2022Cited by 8